Preventing Early Childhood Caries With Silver Diamine Fluoride

Sponsor
The University of Hong Kong (Other)
Overall Status
Recruiting
CT.gov ID
NCT04075474
Collaborator
(none)
730
1
2
32.1
22.8

Study Details

Study Description

Brief Summary

Background: Silver diamine fluoride (SDF) solution is effective in arresting early childhood caries (ECC). Previous studies suggested that it might exert a preventive effect in managing ECC. However, no well-designed clinical trial has been performed to study this topic. The aim of this randomised clinical trial is to assess whether 38% SDF is superior to 5% sodium fluoride (NaF) varnish in preventing new carious lesions in primary anterior teeth.

Methods/Design: This is a Phase II single-centre randomized, double-blind, active-controlled, parallel-group pragmatic trial. The hypothesis tested is that 38% SDF is more effective than 5% NaF in preventing new caries development in primary anterior teeth. Approximately 2,100 three-year-old kindergarten children who are generally healthy and with parental consent will be recruited. This sample size is sufficient for an appropriate statistical analysis of superiority trial with power at 80%, allowing for a 15% drop-out rate. Stratified randomization will be adopted for the intervention allocation. The intervention is either 38% SDF or 5% NaF (as positive control) therapy on primary upper anterior teeth. Dental examination followed by fluoride therapy will be conducted every six months until 30 months in kindergartens by a single examiner. The examiner, children and children's parents will be blinded to the treatment allocation. Questionnaire survey will be conducted to study the children's oral health-related behaviours and their socioeconomic backgrounds.

Discussion: The effectiveness of 38% SDF in preventing ECC remains uncertain. If the results are as anticipated, it will help change the standard of care that using 5% NaF for ECC prevention. In addition, the results will be widely available and increase adoption of SDF in other countries to reduce the global burden of ECC.

Condition or Disease Intervention/Treatment Phase
  • Device: silver diamine fluoride
  • Device: sodium fluoride
Phase 2

Study Design

Study Type:
Interventional
Anticipated Enrollment :
730 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Preventing Early Childhood Caries With Silver Diamine Fluoride - a Randomised Clinical Trial
Actual Study Start Date :
Oct 27, 2020
Anticipated Primary Completion Date :
Jun 30, 2023
Anticipated Study Completion Date :
Jun 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: silver diamine fluoride

38% silver diamine fluoride

Device: silver diamine fluoride
38% SDF on primary upper anterior teeth

Active Comparator: sodium fluoride

5% sodium fluoride

Device: sodium fluoride
5% NaF on primary upper anterior teeth

Outcome Measures

Primary Outcome Measures

  1. caries prevention [at 30-month follow-up]

    the number of sound tooth surfaces that become cavitated caries per child

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 4 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • generally healthy, with parental consents
Exclusion Criteria:
  • uncooperative and difficult to manage, have major systemic diseases such as porphyria, or are on long-term medication such as anti-epileptic drugs.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Local kindergartens Hong Kong Hong Kong

Sponsors and Collaborators

  • The University of Hong Kong

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Chun-Hung Chu, Clinical Professor, The University of Hong Kong
ClinicalTrials.gov Identifier:
NCT04075474
Other Study ID Numbers:
  • UW18-619
First Posted:
Aug 30, 2019
Last Update Posted:
Nov 4, 2020
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 4, 2020